Clinical Trial Update: Methylphenidate Treatment of Cancer-Related Fatigue [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting on methylphenidate for cancer-related fatigue in Phase 2 and Phase 3; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Fatigue

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Medice Arzneimittel Pütter GmbH & Co KG | Conditions: Cancer-related Fatigue | Phase 2, Phase 3 | Status: COMPLETED